AAPL329.89-3.19 (-0.96%) ▼|ABBV262.61+0.84 (+0.32%) ▲|ABT101.85-1.24 (-1.20%) ▼|ACN196.97+1.97 (+1.01%) ▲|ADBE263.14-2.46 (-0.93%) ▼|AMAT418.01-6.21 (-1.46%) ▼|AMD503.78+10.37 (+2.10%) ▲|AMGN378.07-3.43 (-0.90%) ▼|AMT177.02+0.08 (+0.05%) ▲|AMZN248.57-4.97 (-1.96%) ▼|AVGO338.56-6.16 (-1.79%) ▼|AXP324.25-3.53 (-1.08%) ▼|BA210.81+0.54 (+0.25%) ▲|BAC59.53+0.06 (+0.09%) ▲|BKNG171.48-3.87 (-2.21%) ▼|BLK1,054.53-11.07 (-1.04%) ▼|BMY63.77-0.33 (-0.51%) ▼|BNY155.08-2.58 (-1.64%) ▼|BRK-B514.82-0.13 (-0.03%) ▼|C135.48-0.71 (-0.52%) ▼|CAT784.42+0.42 (+0.05%) ▲|CL87.27-0.62 (-0.71%) ▼|CMCSA24.64-0.25 (-0.98%) ▼|COF206.21-0.47 (-0.23%) ▼|COP141.42+4.75 (+3.47%) ▲|COST908.25-10.66 (-1.16%) ▼|CRM259.90+0.47 (+0.18%) ▲|CSCO109.96-0.11 (-0.10%) ▼|CVS94.68-0.87 (-0.91%) ▼|CVX216.90+4.73 (+2.23%) ▲|DE688.12+6.66 (+0.98%) ▲|DHR207.33+4.08 (+2.01%) ▲|DIS107.39-1.20 (-1.11%) ▼|DUK118.11-0.91 (-0.76%) ▼|EMR146.92-1.38 (-0.93%) ▼|FDX309.38-3.19 (-1.02%) ▼|GD357.96+1.15 (+0.32%) ▲|GE309.33-8.23 (-2.59%) ▼|GEV879.12+4.36 (+0.50%) ▲|GILD145.45-0.14 (-0.10%) ▼|GM85.64-1.52 (-1.74%) ▼|GOOG339.69-6.02 (-1.74%) ▼|GOOGL343.19-6.20 (-1.77%) ▼|GS960.68-27.77 (-2.81%) ▼|HD307.53-3.34 (-1.07%) ▼|HON200.72-0.66 (-0.33%) ▼|IBM250.64+1.55 (+0.62%) ▲|INTC97.67+0.48 (+0.49%) ▲|INTU337.51-1.64 (-0.48%) ▼|ISRG376.82-1.12 (-0.30%) ▼|JNJ264.65-1.68 (-0.63%) ▼|JPM345.28-4.85 (-1.39%) ▼|KO88.45-0.38 (-0.42%) ▼|LIN462.65-1.76 (-0.38%) ▼|LLY1,141.46+3.18 (+0.28%) ▲|LMT533.64+4.26 (+0.80%) ▲|LOW195.46-2.71 (-1.37%) ▼|LRCX267.16-6.33 (-2.31%) ▼|MA571.70-2.72 (-0.47%) ▼|MCD254.19-3.30 (-1.28%) ▼|MDLZ62.15-0.25 (-0.39%) ▼|MDT94.03+0.23 (+0.25%) ▲|META666.36+0.76 (+0.11%) ▲|MMM164.31+2.29 (+1.41%) ▲|MO70.13+0.63 (+0.90%) ▲|MRK143.63-0.37 (-0.26%) ▼|MS202.75-3.84 (-1.86%) ▼|MSFT499.41-6.00 (-1.19%) ▼|MU924.85+0.82 (+0.09%) ▲|NEE81.61-0.03 (-0.03%) ▼|NFLX78.33-1.99 (-2.48%) ▼|NKE36.43-0.62 (-1.67%) ▼|NOW145.11+2.76 (+1.94%) ▲|NVDA211.67+0.71 (+0.34%) ▲|ORCL143.08-1.71 (-1.18%) ▼|PEP135.46-0.88 (-0.65%) ▼|PFE27.49-0.24 (-0.85%) ▼|PG147.08+0.95 (+0.65%) ▲|PLTR176.17+2.86 (+1.65%) ▲|PM193.19-1.68 (-0.86%) ▼|QCOM188.57+8.42 (+4.67%) ▲|RTX195.71+0.37 (+0.19%) ▲|SBUX96.62-2.46 (-2.48%) ▼|SCHW108.19+0.88 (+0.82%) ▲|SO86.29-0.71 (-0.82%) ▼|SPG203.98-0.99 (-0.48%) ▼|T26.82+0.31 (+1.17%) ▲|TMO636.22+23.07 (+3.76%) ▲|TMUS181.40-1.50 (-0.82%) ▼|TSLA357.10-1.88 (-0.52%) ▼|TXN263.61+0.19 (+0.07%) ▲|UBER71.93-0.70 (-0.96%) ▼|UNH376.31-7.24 (-1.89%) ▼|UNP284.83-0.25 (-0.09%) ▼|UPS102.58+0.12 (+0.12%) ▲|USB62.28-0.40 (-0.64%) ▼|V374.81-0.47 (-0.13%) ▼|VZ51.57+0.28 (+0.55%) ▲|WFC89.07+0.36 (+0.41%) ▲|WMT108.70-0.38 (-0.35%) ▼|XOM169.31+4.23 (+2.56%) ▲|AAPL329.89-3.19 (-0.96%) ▼|ABBV262.61+0.84 (+0.32%) ▲|ABT101.85-1.24 (-1.20%) ▼|ACN196.97+1.97 (+1.01%) ▲|ADBE263.14-2.46 (-0.93%) ▼|AMAT418.01-6.21 (-1.46%) ▼|AMD503.78+10.37 (+2.10%) ▲|AMGN378.07-3.43 (-0.90%) ▼|AMT177.02+0.08 (+0.05%) ▲|AMZN248.57-4.97 (-1.96%) ▼|AVGO338.56-6.16 (-1.79%) ▼|AXP324.25-3.53 (-1.08%) ▼|BA210.81+0.54 (+0.25%) ▲|BAC59.53+0.06 (+0.09%) ▲|BKNG171.48-3.87 (-2.21%) ▼|BLK1,054.53-11.07 (-1.04%) ▼|BMY63.77-0.33 (-0.51%) ▼|BNY155.08-2.58 (-1.64%) ▼|BRK-B514.82-0.13 (-0.03%) ▼|C135.48-0.71 (-0.52%) ▼|CAT784.42+0.42 (+0.05%) ▲|CL87.27-0.62 (-0.71%) ▼|CMCSA24.64-0.25 (-0.98%) ▼|COF206.21-0.47 (-0.23%) ▼|COP141.42+4.75 (+3.47%) ▲|COST908.25-10.66 (-1.16%) ▼|CRM259.90+0.47 (+0.18%) ▲|CSCO109.96-0.11 (-0.10%) ▼|CVS94.68-0.87 (-0.91%) ▼|CVX216.90+4.73 (+2.23%) ▲|DE688.12+6.66 (+0.98%) ▲|DHR207.33+4.08 (+2.01%) ▲|DIS107.39-1.20 (-1.11%) ▼|DUK118.11-0.91 (-0.76%) ▼|EMR146.92-1.38 (-0.93%) ▼|FDX309.38-3.19 (-1.02%) ▼|GD357.96+1.15 (+0.32%) ▲|GE309.33-8.23 (-2.59%) ▼|GEV879.12+4.36 (+0.50%) ▲|GILD145.45-0.14 (-0.10%) ▼|GM85.64-1.52 (-1.74%) ▼|GOOG339.69-6.02 (-1.74%) ▼|GOOGL343.19-6.20 (-1.77%) ▼|GS960.68-27.77 (-2.81%) ▼|HD307.53-3.34 (-1.07%) ▼|HON200.72-0.66 (-0.33%) ▼|IBM250.64+1.55 (+0.62%) ▲|INTC97.67+0.48 (+0.49%) ▲|INTU337.51-1.64 (-0.48%) ▼|ISRG376.82-1.12 (-0.30%) ▼|JNJ264.65-1.68 (-0.63%) ▼|JPM345.28-4.85 (-1.39%) ▼|KO88.45-0.38 (-0.42%) ▼|LIN462.65-1.76 (-0.38%) ▼|LLY1,141.46+3.18 (+0.28%) ▲|LMT533.64+4.26 (+0.80%) ▲|LOW195.46-2.71 (-1.37%) ▼|LRCX267.16-6.33 (-2.31%) ▼|MA571.70-2.72 (-0.47%) ▼|MCD254.19-3.30 (-1.28%) ▼|MDLZ62.15-0.25 (-0.39%) ▼|MDT94.03+0.23 (+0.25%) ▲|META666.36+0.76 (+0.11%) ▲|MMM164.31+2.29 (+1.41%) ▲|MO70.13+0.63 (+0.90%) ▲|MRK143.63-0.37 (-0.26%) ▼|MS202.75-3.84 (-1.86%) ▼|MSFT499.41-6.00 (-1.19%) ▼|MU924.85+0.82 (+0.09%) ▲|NEE81.61-0.03 (-0.03%) ▼|NFLX78.33-1.99 (-2.48%) ▼|NKE36.43-0.62 (-1.67%) ▼|NOW145.11+2.76 (+1.94%) ▲|NVDA211.67+0.71 (+0.34%) ▲|ORCL143.08-1.71 (-1.18%) ▼|PEP135.46-0.88 (-0.65%) ▼|PFE27.49-0.24 (-0.85%) ▼|PG147.08+0.95 (+0.65%) ▲|PLTR176.17+2.86 (+1.65%) ▲|PM193.19-1.68 (-0.86%) ▼|QCOM188.57+8.42 (+4.67%) ▲|RTX195.71+0.37 (+0.19%) ▲|SBUX96.62-2.46 (-2.48%) ▼|SCHW108.19+0.88 (+0.82%) ▲|SO86.29-0.71 (-0.82%) ▼|SPG203.98-0.99 (-0.48%) ▼|T26.82+0.31 (+1.17%) ▲|TMO636.22+23.07 (+3.76%) ▲|TMUS181.40-1.50 (-0.82%) ▼|TSLA357.10-1.88 (-0.52%) ▼|TXN263.61+0.19 (+0.07%) ▲|UBER71.93-0.70 (-0.96%) ▼|UNH376.31-7.24 (-1.89%) ▼|UNP284.83-0.25 (-0.09%) ▼|UPS102.58+0.12 (+0.12%) ▲|USB62.28-0.40 (-0.64%) ▼|V374.81-0.47 (-0.13%) ▼|VZ51.57+0.28 (+0.55%) ▲|WFC89.07+0.36 (+0.41%) ▲|WMT108.70-0.38 (-0.35%) ▼|XOM169.31+4.23 (+2.56%) ▲|
22.6 C
New York
Tuesday, September 15, 2026

Tag: events

newssourceFORcompanyinformationcontent1releasesmarket

FDA Approves Apellis’ EMPAVELI® (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older

WALTHAM, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the U.S. Food and Drug Administration (FDA) has approved EMPAVELI® (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G) or primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) in patients 12 years of age and older, to reduce proteinuria. C3G and primary IC-MPGN are rare kidney diseases, affecting 5,000 people in the United States.1

Invesque Inc. Completes Disposition of 11 Seniors Housing Assets and Manager Changes at Four Other Properties

TORONTO, July 28, 2025 /CNW/ - Invesque Inc. (the "Company" or "Invesque") (TSX: IVQ) (TSX: IVQ.U) announced today that over the last 40 days...

First Central Savings Bank Reports Second Quarter 2025 Results Highlighted by Net Income of $1.6 million ($0.15 EPS), Net Interest Margin Expansion by 17...

Performance Highlights

H2O America Announces Second Quarter 2025 Financial Results

H2O America reports second quarter 2025 financial results and hosts a live webcast on Tuesday, July 29, 2025 at 2 p.m. (ET).

Live Oak Bancshares, Inc. Prices Depositary Share Offering

WILMINGTON, N.C., July 28, 2025 (GLOBE NEWSWIRE) -- Live Oak Bancshares, Inc. (NYSE: LOB) (“Live Oak” or the “Company”) announced the pricing of an underwritten offering of 4,000,000 depositary shares, each representing a 1/40th ownership interest in a share of 8.375% Fixed Rate Series A Non-Cumulative Perpetual Preferred Stock (the “Series A Preferred Stock”), with a liquidation preference of $25 per depositary share.

Alpha-synuclein Inhibitors Market to Witness Strong CAGR Through 2034, Driven by Advances in Neurodegenerative Therapies | DelveInsight

No alpha-synuclein inhibitors are approved, underscoring a major need for therapies that slow or halt Parkinson's progression. Developing safe, brain-penetrant drugs that target toxic...

GBank Financial Holdings Inc. Announces Second Quarter 2025 Financial Results

GBank Financial Holdings Inc. Announces Second Quarter 2025 Financial Results

Qualigen Therapeutics Provides Update on Nasdaq Communications and Continued Listing Status

CARLSBAD, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) received two different communications from the staff of the Nasdaq Listing Qualifications office of the Nasdaq Stock Market, LLC. The Company received the first notice from the Nasdaq Listings Qualifications office of the Nasdaq Stock Market LLC on July 23, 2025, informing the Company that as reflected in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 filed with the SEC on July 21, 2025, the Company failed to comply with the $2.5 million stockholder’s equity required under Nasdaq Rule 5550(b)(1) (the “Equity Rule”) or any alternative standard under Nasdaq 5550(b).

Paramount Global to Report Second Quarter 2025 Financial Results on July 31, 2025

NEW YORK, July 28, 2025 /PRNewswire/ -- Paramount Global (NASDAQ: PARA, PARAA) announced today that it will report second quarter 2025 financial results on...

BlackLine Appoints Greg Hughes to Board of Directors, Expanding Enterprise Software and Strategic Growth Expertise

LOS ANGELES, July 29, 2025 /PRNewswire/ -- BlackLine, Inc. (Nasdaq: BL), the future-ready financial operations platform for the Office of the CFO, today announced...

RCLCO Mid-Year Report Ranks Summerlin® and Bridgeland® Among Nation’s Top-Selling Master Planned Communities

Summerlin® and Bridgeland®, two of the award-winning communities in the Howard Hughes Holdings portfolio, have been ranked among the country's

Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering

WOBURN, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- This press release corrects a version issued on July 25, 2025 that incorrectly listed KCSA Strategic Communications as iSpecimen’s investor relations contact. KCSA is not currently affiliated with iSpecimen Inc. and was mistakenly included in the prior release. The corrected release is below in its entirety.

In Celebration of Tony Bennett’s Birthday, CARNEGIE HALL+ Announces the Streaming Premiere of BECAUSE OF YOU, Michael Feinstein’s Concert Tribute to Tony Bennett, Beginning...

Special streaming premiere of performance featuring the Carnegie Hall Big Band, filmed on tour at Segerstrom Center for the Arts, available for the first...

TOPAZ REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS DEMONSTRATING STRONG ROYALTY AND INFRASTRUCTURE GROWTH

CALGARY, AB, July 28, 2025 /CNW/ - Topaz Energy Corp. (TSX: TPZ) ("Topaz" or the "Company") is pleased to provide second quarter 2025 financial...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsEvents

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers